TNF-α and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling
Authors:
- 1 April 2002
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 282 (4) , H1288-H1295
Abstract
The cytokine tumor necrosis factor (TNF)-α has been causally linked to left ventricular (LV) remodeling, but the molecular basis for this effect is unknown. Matrix metalloproteinases (MMPs) have been implicated in cardiac remodeling and can be regulated by TNF-α. This study tested the central hypothesis that administration of a TNF-α blocking protein would prevent the induction of MMPs and alter the course of myocardial remodeling in developing LV failure. Adult dogs were randomly assigned to the following groups: 1) chronic pacing (250 beats/min, 28 days, n = 12), 2) chronic pacing with concomitant administration of a TNF-α blocking protein (TNF block) using a soluble p75 TNF receptor fusion protein (TNFR:Fc; administered at 0.5 mg/kg twice a week subcutaneously, n = 7), and 3) normal controls ( n = 10). LV end-diastolic volume increased from control with chronic pacing (83 ± 12 vs. 118 ± 10 ml, P < 0.05) and was reduced with TNF block (97 ± 9 ml, P < 0.05). MMP zymographic levels (92 kDa, pixels) increased from control with chronic pacing (36,848 ± 9,593 vs. 87,247 ± 12,912, P < 0.05) and was normalized by TNF block. Myocardial MMP-9 and MMP-13 levels by immunoblot increased with chronic pacing relative to controls (130 ± 10% and 118 ± 6%, P < 0.05) and was normalized by TNF block. These results provide evidence to suggest that TNF-α contributes to the myocardial remodeling process in evolving heart failure through the local induction of specific MMPs.Keywords
This publication has 34 references indexed in Scilit:
- Cytokines and Cytokine Receptors in Advanced Heart FailureCirculation, 2001
- Disruption of the myocardial extracellular matrix leads to cardiac dysfunctionJournal of Clinical Investigation, 2000
- Matrix metalloproteinases: not-so-innocent bystanders in heart failureJournal of Clinical Investigation, 2000
- Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarctionJournal of Clinical Investigation, 2000
- Clinical implications of tumour necrosis factor α antagonism in patients with congestive heart failureAnnals of the Rheumatic Diseases, 1999
- A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving MethotrexateNew England Journal of Medicine, 1999
- Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4Journal of Biological Chemistry, 1996
- Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failureJACC, 1996
- Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II.Circulation Research, 1994
- Left ventricular volume determined echocardiographically by assuming a constant left ventricular epicardial long-axis/ short-axis dimension ratio throughout the cardiac cycleJACC, 1992